Scientific Information

Organising Institutions

International Foundation for Maternal Periconceptional and Peri- neonatal Medicine (FIMPP) founded by a group of highly professional and enthusiastic obstetricians and neonatologists, the worldwide known experts in the field that aim to revive the interest around maternal and neonatal care.
FIMPP is composed of Board of Directors, chaired by Prof. Gian Carlo Di Renzo from Italy and Board of Scientific Advisors, chaired by Prof. Umberto Simeoni from Switzerland.
The purpose of FIMPP is to foster education, research and advocacy in maternal, periconceptional and neonatal medicine and care worldwide. The Foundation aims to promote and disseminate the study, research and knowledge on the aspects of maternal, periconceptional and neonatal medicine, in order to attain, by appropriate means, a higher level of physical and mental health for women,
mothers, and their children.
Collaboration between various disciplines interested in maternal, perception, and perinatal care as well as friendship between individuals from different world countries will lead to improving the quality and provision of care in the world.

Congress Committees

Congress Presidents
 

Scientific Committee

Scientific Committee
 
 
 
 
 

Scientific Programme

09:00-09:05

WELCOME FROM CONGRESS PRESIDENTS

Yves Ville, France / Francesco Raimondi, Italy / Efraim Bilavsky, Israel

09:05-11:10

SESSION 1 – Prenatal Management of maternal primary infections, State of the science and gaps

Moderators: Yves VILLE - Jacob AMIR

09:05-09:25

Maternal serologies made (more or less) easy

Marianne Leruez

09:25-09:45

Secondary Prevention following maternal primary infection:

Christros Chatzakis

09:50-10:00

Non-invasive prediction of fetal infection by ultrasound

Nicolas Bourgon

10:05-10:15

Non-invasive prediction of fetal infection in maternal blood

Brigitte Faas

10:20-10:30

Chorionic villus sampling or amniocentesis for prenatal diagnosis?

Jacques Fourgeau

10:35-10:55

Negative amniocentesis with or without maternal anti-viral treatment – what are the clinical implications?

Jacob Amir, Israel

11:00-11:15

ECCI & ESCV Prenatal Recommendations

TBA

11:15-11:35

COFFEE BREAK

11:35-13:00

SESSION 2 –Oral communications

Moderators: Daniele Lilleri - Marianne Leruez

13:00-14:00

LUNCH / POSTER VIEWING

14:00-15:45

SESSION 3 – Interactive cases

Moderators: Tiziana Lazzaroto - Anna Gonce

14:00-14:45

Tricky cases

Jacques Fourgeau & Nicolas Bourgon

14:45-15:45

Your cases !

15:45-16:15

COFFEE BREAK

16:15-17:30

SESSION 3 - Long term sequelae and impact of Newborn Universal screening

Moderators: Ana Alarcon-Francesco Raimondi

16:15-16:35

Optimizing Outcomes in Children with Congenital CMV through Early Hearing

Intervention Sharon Cushing, Canada

16:35-17:15

Debate: Universal Neonatal screening

16:35-16:55

Yes: Mark Schleiss

16:55-17:15

No: Daniel Blasquez

17:15-17:35

Impact of behavioral disorders in management of hearing loss in congenital CMV

Natacha Teissier, Franch

17:35-17:45

(ID ?) accepted oral presentation

17:50-18:00

(ID ?) accepted oral presentation

18:00-18:15

Discussion

09:00-11:15

SESSION 4 – Fetal infection - Prognosis

Moderators: Ana Gonce - Daniel Blasquez

09:00-09:20

The prognosis of an infected fetus: Overview

Yves Ville

09:20-09:40

Fetal prognosis following failure of secondary prevention

Nicolas Bourgon

09:40-10:00

Intrauterine treatment, pharmacological update

Valentine Faure-Bardon

10:00-10:20

Prenatal and Postnatal MRI in infected fetuses and neonates

Ana Alarcon

10:20-10:50

Cases discussion

10:50-11:00

(ID ?) – accepted oral presentation

11:00-11:10

(ID ?) - accepted oral presentation

11:10-11:20

(ID ?) - accepted oral presentation

11:20-11:50

COFFEE BREAK

11:50-12:15

Postnatal recommendation of ECCI-ESC V

TBA

12:20-13:30

LUNCH AND POSTER VIEWING

13:30-16:05

SESSION 5 - Hearing and vestibular sequela in children with cCMV

Moderators: ?

13:00-13:20

Long term vestibular function in cCMV

Natacha Teissier, Franch

13:20-13:40

Long-term Hearing Instability in Children with Congenital CMV

Sharon Cushing, Canada

13:40-14:00

Profound hearing loss in children with cCMV infection: What is the impact in daily life?

Ina Foulon

14:00-14:15

Discussion

14:15-14:25

(ID ?) – accepted oral presentation

14:25-14:35

(ID ?) – accepted oral presentation

14:35-14:45

(ID ?) – accepted oral presentation

14:45-14:55

(ID ?) – accepted oral presentation

14:55-15:05

(ID ?) – accepted oral presentation

15:05-15:30

COFFEE BREAK

15:30-15:40

(ID ?) – accepted oral presentation

15:40-15:50

(ID ?) – accepted oral presentation

15:50-16:05

Discussion

16:05-16:35

CLOSING REMARKS

Yves Ville, Francesco Raimondi, Efraim Bilavsky